Galileo Research Facts No. 51: Can 3 weeks of Galileo Therapy improve joint sensitivity and gait in CP patients?
As shown by other studies (#GRFS130, #GRFS56, #GRFS30, #GRFS14 #GRFS13) this study once more shows how effective and save Galileo Therapy can be applied in Children with CP (Cerebral Palsy). Interestingly, only 6 interventions of 3 times 3 minutes Galileo Therapy were used to achieve these results. In addition, each session included 30 minutes of standard physio therapy (gait, stretching, spasticity reduction – this would have been a great application for Galileo Therapy as well #GRFS64, #GRFS40). Nevertheless: the additional 9 minutes of Galileo Therapy had more than 3 times the effect of the additional standard therapy with effects on gait and joint position sense (JPS) of up to 54%. To achieve this the study used a very simple exercise: 20-24Hz, position 2, 30° bent knees.
The study shows one major advantage of Galileo Therapy: first neuro-muscular effects of the Galileo therapy can usually be seen within minutes – therefore, if the right exercise for the aimed therapy effect is used the aimed effect should become visible within minutes (apart from increase of muscle and bone mass (#GRFS72) or endurance which take a little longer). This helps to optimize therapy because after each exercise there should be an immediate positive effect.
#GRFS51 #GalileoTherapy #CP #GalileoCP #CerebralPalsy #Gait #GalileoKids #MechanoStimulation
The verdict of our customers: Excellent
4.7 out of 5 stars based on 868 reviews
Since 1996 we support our Galileo® customers worldwide.
Development and production exclusively in Germany.
10-year service guarantee &
5 year warranty for private customers in Germany
Unlimited user support for all Galileo customers.
Efficacy proven by over 500 scientific publications.
© 2008-2025 Novotec Medical GmbH
You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More Information